https://orcid.org/0000-0002-5859-1945
Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Hazal Cansu Çulpan, Sümeyye Nur Aydın, Abdulkerim Uygur, Uğurcan Sayılı, Erkam Şeker, İ̇lker İnanç Balkan, Rıdvan Karaali, Beyhan Budak, Yılmaz Keskindemirci, Neşe Saltoğlu & Günay Can. (2023) Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers. Human Vaccines & Immunotherapeutics 19:3.
Read now
Read now
Articles from other publishers (12)
Ekta Krishna, Venkatesh Karthikeyan, Shamshad Ahmad, Alok Ranjan, Abul Hasan KM, Sanjay Pandey, Pragya Kumar & CM Singh. (2023) Acceptance of Annual Booster Doses of COVID-19 Vaccines Among Indian Healthcare Professionals: A Pan-India Cross-Sectional Survey. Cureus.
Crossref
Crossref
Ting Zeng, Yaoqin Lu, Yanji Zhao, Zihao Guo, Shengzhi Sun, Zhidong Teng, Maozai Tian, Jun Wang, Shulin Li, Xucheng Fan, Weiming Wang, Yongli Cai, Gengze Liao, Xiao Liang, Daihai He, Kai Wang & Shi Zhao. (2023) Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts. Respiratory Research 24:1.
Crossref
Crossref
Hailey J Park, Sophia T Tan, Tomás M León, Seema Jain, Robert Schechter & Nathan C Lo. (2023) Predicting the Public Health Impact of Bivalent Vaccines and Nirmatrelvir-Ritonavir Against Coronavirus Disease 2019. Open Forum Infectious Diseases 10:9.
Crossref
Crossref
Christoph Hieber, Stephan Grabbe & Matthias Bros. (2023) Counteracting Immunosenescence—Which Therapeutic Strategies Are Promising?. Biomolecules 13:7, pages 1085.
Crossref
Crossref
Parham Sendi, Nadja Widmer, Mattia Branca, Marc Thierstein, Annina Elisabeth Büchi, Dominik Güntensperger, Manuel Raphael Blum, Rossella Baldan, Caroline Tinguely, Dik Heg, Elitza S. Theel, Elie Berbari, Aaron J. Tande, Andrea Endimiani, Peter Gowland & Christoph Niederhauser. (2023) Do quantitative levels of antispike‐IgG antibodies aid in predicting protection from SARS‐CoV‐2 infection? Results from a longitudinal study in a police cohort. Journal of Medical Virology 95:7.
Crossref
Crossref
Branden Lee, Etsuro Nanishi, Ofer Levy & David J. Dowling. (2023) Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations. Pharmaceutics 15:6, pages 1766.
Crossref
Crossref
Omar Yaxmehen Bello-Chavolla, Neftali Eduardo Antonio-Villa, Sergio Iván Valdés-Ferrer, Carlos A. Fermín-Martínez, Luisa Fernández-Chirino, Arsenio Vargas-Vázquez, Daniel Ramírez-García, Javier Mancilla-Galindo, Ashuin Kammar-García, José Alberto Ávila-Funes, Clemente Humberto Zúñiga-Gil, Miguel García-Grimshaw, Santa Elizabeth Ceballos-Liceaga, Guillermo Carbajal-Sandoval, José Antonio Montes-González, Christian Arturo Zaragoza-Jiménez, Gabriel García-Rodríguez, Ricardo Cortés-Alcalá, Gustavo Reyes-Terán, Hugo López-Gatell & Luis Miguel Gutiérrez-Robledo. (2023) Effectiveness of a nationwide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data. International Journal of Infectious Diseases 129, pages 188-196.
Crossref
Crossref
Nicole Ngai Yung Tsang, Hau Chi So, Benjamin J Cowling, Gabriel M Leung & Dennis Kai Ming Ip. (2023) Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study. The Lancet Infectious Diseases 23:4, pages 421-434.
Crossref
Crossref
Ruby Pawankar, Bernard Yu‐Hor Thong, Marysia Tiongco‐Recto, Jiu‐Yao Wang, Amir Hamzah Abdul Latiff, Ting Fan Leung, Philip Hei Li, Rommel Crisenio M. Lobo, Michela Lucas, Jae‐Won Oh, Wasu Kamchaisatian, Mizuho Nagao, Iris Rengganis, Zarir F. Udwadia, Raja Dhar, Sonomjamts Munkhbayarlakh, Logii Narantsetseg, Duy Le Pham, Yuan Zhang & Luo Zhang. (2022)
Asia Pacific
perspectives on the second year of the
COVID
‐19 pandemic: A follow‐up survey
. Clinical & Experimental Allergy 52:8, pages 965-973.
Crossref
Crossref
Alexis Sentís, Irina Kislaya, Nathalie Nicolay, Hinta Meijerink, Jostein Starrfelt, Iván Martínez-Baz, Jesús Castilla, Katrine Finderup Nielsen, Christian Holm Hansen, Hanne-Dorthe Emborg, Anthony Nardone, Tarik Derrough, Marta Valenciano, Baltazar Nunes & Susana Monge. (2022) Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022. Eurosurveillance 27:30.
Crossref
Crossref
Sergio Gil-Manso, Diego Carbonell, Verónica Astrid Pérez-Fernández, Rocío López-Esteban, Roberto Alonso, Patricia Muñoz, Jordi Ochando, Ignacio Sánchez-Arcilla, Jose M Bellón, Rafael Correa-Rocha & Marjorie Pion. (2022) Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines. Biomedicines 10:7, pages 1676.
Crossref
Crossref
Nicole Ngai Yung Tsang, Hau Chi So, Benjamin J. Cowling, Gabriel Leung & Dennis Kai Ming Ip. (2022) Effectiveness of BNT162b2 and CoronaVac COVID-19 Vaccination Against Asymptomatic and Symptomatic Infection of SARS-CoV-2 Omicron BA.2 in Hong Kong. SSRN Electronic Journal.
Crossref
Crossref